G6PD and acute myeloid leukemia: Glucose-6-phosphate dehydrogenase (G6PD) is the first enzyme in the PPP pathway, whose inhibitor 6-aminonicotinamide (6AN) induces cytotoxicity against AML cells in vitro and in vivo (34).